The world's first whole-body portable ultrasound continues its rapid global expansion and distribution, while demonstrating significant clinical utility in fighting the COVID-19 pandemic
GUILFORD, CT, March 27, 2020 /CNW/ - Butterfly Network, the company helping to transform healthcare with its disruptive, Ultrasound-on-Chip™ technology, announced today that after priority review by Health Canada, it has received medical device licensing for its point-of-care ultrasound device. The Butterfly iQ is now available to Canadian healthcare practitioners and health systems.
"As healthcare practitioners work to combat the COVID-19 pandemic that is overwhelming our healthcare systems, it is more important than ever that they have access to tools and resources to help them in this fight. Aligned with our mission of democratizing medical imaging, we are proud to offer Canada access to affordable, portable and state-of-the-art technology to better help them monitor and triage affected patients both quickly and effectively," said Laurent Faracci, who assumes his role as Butterfly CEO on April 1.
Butterfly Network is working closely with both Health Canada and leading physicians and healthcare systems across the provinces to ensure proper access and use of Butterfly iQ devices, particularly at this critical health moment.
"A growing body of evidence shows that point-of-care ultrasound is a critical tool for triaging and monitoring patients impacted by COVID-19 and we have heard the same from hundreds of clinicians from around the world," said Dr. John Martin, Butterfly's Chief Medical Officer. "Canadian healthcare practitioners, on the front lines of this pandemic, can now access the Butterfly iQ to perform lung ultrasound at the point of care which has been effective in detecting pulmonary involvement in suspected COVID-19 patients."
Dr. Adam Thomas, emergency physician in Island Health, Victoria BC and ICU fellow in Vancouver BC, is using the Butterfly iQ for rapid pulmonary involvement assessment of COVID-19 patients.
"Given current constraints on healthcare, from timing to surge capacity, we are not going to be able to use some of the traditional assessments and treatment options. We must turn to solutions that can help us be more efficient and effective, and focus on helping patients. No tool may do that better than Butterfly," said Dr. Thomas. "The Butterfly iQ has the ability to complete essential functions quickly and safely and in a way that integrates smoothly with hospital workflow. This tool can help us combat the spread of this pandemic."
In just one year since its commercial launch, Butterfly expanded its commercial presence to 20 markets and has become a leader in handheld ultrasound. It is currently used by over 15,000 healthcare practitioners around the world. To date, the company has raised more than $350 million of capital from leading investors, including Fidelity, Fosun Pharma and the Gates Foundation.
To learn more about Butterfly's launch in Canada or to purchase a device (for healthcare practitioners only), visit:
About Butterfly Network Founded by Dr. Jonathan Rothberg in 2011, Butterfly Network has created the world's first handheld, single-probe whole-body ultrasound system, Butterfly iQ, making ultrasound technology universally accessible and affordable. Butterfly Network's mission is to democratize healthcare for the 4.7 billion people around the world lacking access to medical imaging. Through their patented Ultrasound-On-Chip™ technology, Butterfly Network is paving the way for earlier detection and remote management of health conditions around the world.
SOURCE Butterfly Network, Inc.
Harris County Public Health and Local HealthTech Company Luminare Partner to Launch COVID-19 Self-Assessment Tool to Help Prioritize Testing for High-Risk Individuals
HOUSTON, TX -- Harris County Public Health (HCPH) andLuminare, Inc., in collaboration with Microsoft for Startups, developed QuickScreen, an online assessment tool designed for individuals to provide guidance on whether they should be tested for coronavirus disease (COVID-19).
“We understand that there are a lot of questions and misinformation about coronavirus disease,” said Umair A. Shah, MD, MPH, executive director and local health authority for Harris County Public Health. “This innovative tool will help individuals self-assess to understand if they are truly at risk for COVID-19 or if their symptoms could be related to another health condition.”
QuickScreen is an online, confidential and secure self-assessment tool that can be used at home. This web-based software is designed initially to serve the public in the Greater Houston area in accordance with the Center for Disease Control and Prevention Coronavirus guidelines.
The goal is to empower individuals to understand if they are at risk for COVID-19 and to seek medical attention accordingly so exposure to the community can be limited. In addition, the COVID-19 self-assessment platform will help decrease potential exposure to healthcare workers, avoid emergency room overcrowding, and allow efficient communication between the health department and the population at large.
“After years spent tackling sepsis, we have considerably built up our core product at Luminare and are now leveraging our expertise and understanding in that area to develop QuickScreen for COVID-19,” stated Luminare CEO & Co-Founder Dr. Sarma Velamuri. He added, “Our hope is that the QuickScreen web portal can help alleviate the stresses being placed on our community’s healthcare facilities and its workers who are on the front lines battling the spread of Coronavirus in Harris County and the region by giving individuals a better indication of whether or not they may need further testing.”
QuickScreen will provide an individual with recommendations, based on Centers for Disease Control and Prevention (CDC) guidelines, on their symptoms and risk factors related to COVID-19. The screening takes less than two minutes on average to complete when an individual has relevant health history available prior to accessing the web portal.
QuickScreen will be another step in keeping the Harris County community safe by quickly and accurately identifying who may need escalated testing and potential medical care to treat the onset of COVID-19. You can access QuickScreen by going www.hcphtx.org\COVID-19 and www.readyharris.org/
Luminare, Inc. is part of the Texas Medical Center Innovation community and is officed at the TMC Innovation campus. Luminare provides software solutions to improve hospital efficiency, with their first product to reduce sepsis mortality and morbidity in the hospital setting.
Parties interested in obtaining access to the software platform should contact covid19@luminaremed.com.
ABOUT LUMINARE
Luminare specializes in building software that automates processes in hospitals so that patients receive timely and appropriate care. Luminare is recipient of the “Most Promising Web & IT Company” by the Rice University Jones School of business ‘17 and was participating in the CDC’s Interoperability Showcase at HIMSS 2020 on “Stopping sepsis through early detection” and is alumnus of the TMC’s Innovation Accelerator. Our primary mission is to stop 250,000 deaths a year in US hospitals from sepsis. When COVID hit we decided to repurpose our sepsis platform and expertise to provide this service. The tool is free and available to communities, government organizations, and healthcare entities beyond Harris County for the purposes of COVID-19 self-assessment. For more information, please visitwww.luminaremed.com.
ABOUT HARRIS COUNTY PUBLIC HEALTH
Harris County Public Health (HCPH) is the health department for Harris County, the third most populous county in the nation. Throughout the years, HCPH has responded to public health issues such as rabies, mosquito-borne illnesses, air and water pollution, disease outbreaks, water and food-borne illnesses, natural disasters, tuberculosis, polio, and other communicable diseases. For its efforts, HCPH was named the 2016 Local Health Department of the year by the National Association of County and City Health Officials (NACCHO).
HCPH is the local public health agency for the Harris County, Texas jurisdiction. It provides a wide variety of public health activities and services aimed at improving the health and well-being of the Harris County community.
Sophie Desmarais donates $500,000 to COVID-19 research at the Jewish General Hospital, urges those who can to "donate generously"
MONTREAL, March 27, 2020 /CNW Telbec/ - A major $500,000 donation from Sophie Desmarais, a passionate philanthropist and member of the well-known Desmarais family, will help propel four high-impact COVID-19 research projects at Montreal's Jewish General Hospital (JGH).
Ms. Desmarais is determined to be a part of the solution in the fight against the worldwide COVID-19 pandemic by providing scientists in the lab with the funding they need to make game-changing discoveries. The results of this research will benefit the global healthcare and scientific communities and advance the development of life-saving drugs, a biobank to predict the treatment of COVID patients, artificial intelligence tools to better predict where the virus will hit, and faster diagnostic tools.
"The Jewish General Hospital is one of the top Hospitals in Quebec, and when they informed me of these projects, I immediately decided to get involved. I am compelled to support our hometown research expertise in the face of this global epidemic," stated Ms. Desmarais when asked why she chose to support the JGH and COVID research in particular. "We are all in this together. We need to come together and support the exceptional efforts made by medical professionals and researchers. It is essential everyone contributes what they can. However, today I am turning to others who, like me, are from families in a position to give more and asking them to donate generously to the Jewish General Hospital to fund COVID-19 research. It is our responsibility. Together we will get there," concluded Ms. Desmarais.
"The JGH is part of a global community and there are no borders when it comes to COVID‑19. We are striving to strengthen efforts in the face of this virus. Ms. Desmarais' commitment toward funding our researchers will change the course of this worldwide pandemic. Funding research projects such as these four initiatives has the potential to save thousands of lives," said Bram Freedman, President and CEO of the JGH Foundation.
Specifically, $150,000 will be dedicated to Dr. Brent Richards' (McGill University and JGH's Lady Davis Research Institute) project to build a biobank that will make predicting optimal treatment for COVID patients possible. Mandated by le Fonds de recherche en santé du Québec (FRSQ) and the Québec Health Ministry, this province-wide bank of data and biological samples will help answer the three pressing questions; which patients can be sent home safely; which will require hospitalization; and how genetics and risk factors can help to develop successful therapies.
Another $150,000 will serve to fund artificial intelligence to predict where the coronavirus will hit and warn at-risk people. Dr. Justin Cross, Chief Digital Health Officer at the JGH and his team, are creating an analytical tool to respond proactively to the pandemic in a data-driven fashion.
$100,000 will be dedicated to developing the right drugs to combat COVID-19. Dr. Chen Liang (McGill University and JGH's Lady Davis Research Institute) and his team are investigating what makes this new coronavirus transmit so rapidly. This project is currently supported by an operating grant from the Canadian Institutes of Health Research. These additional funds will allow the JGH to assemble a stronger research team with more resources to understand the cause of this devastating disease quickly.
Lastly, $100,000 will serve to develop a faster diagnostic tool. Dr. Mark Trifiro (McGill University and JGH's Lady Davis Research Institute) and his team have introduced a completely novel and straightforward way to generate thermocycling, which will reduce the time and footprint required to diagnose COVID-19. Thanks to this project, tests can be performed where the patients are. This additional funding will allow the JGH to jump to a generation 2 prototype where much smaller volumes are used and can allow even faster results (<5 minutes).
ABOUT THE JEWISH GENERAL HOSPITAL FOUNDATION Since 1969, the Jewish General Hospital Foundation has led a dynamic fundraising program in support of the Jewish General Hospital (JGH), one of the province's largest and busiest acute-care hospitals. A McGill University teaching hospital, the JGH is renowned for the excellence of its healthcare and the calibre of its medical and research staff. Thanks to our passionate and generous donors, volunteers and supporters, the JGH can continue to deliver awe-inspiring medical breakthroughs and keep pushing forward, improving lives and patient-centred care. Our donors and supporters can be proud: Newsweek Magazine rated the JGH the #1 hospital in Quebec, #5 in Canada and among the top hospitals in the world.
ABOUT SOPHIE DESMARAIS See separate bio and photo
Ms. Desmarais is available for interviews.
SOURCE Jewish General Hospital Foundation
There is a lo going on right now in the world and even though you may not be sick there are tons of things that you can do to boost your immune system. Here is one of them!
Train It Right Immune Boosting Elixir
-1/4 cup organic NOT FROM CONCENTRATE cranberry juice - 5 pure oil of oregano drops - 5 pure ginger drops - 1/4 teaspoon of turmeric - Sprinkle of cayenne pepper - 1/2 fresh squeezed lemon - 1 tablespoon of apple cider vinegar - sweeten with raw stevia if needed
Directions:
Mix all ingredients together and take as a shot, cold.
Suggest getting ingredients at a health food store such as healthy planet, organic garage , natures emporium, or whole foods.
In addition you can add in pill form of
Zinc – 100 mg Vitamin C – 2000 mg
From Clone to Jar, Autumn Brands Offers a Fascinating Inside Look at the Lifecycle of a Quality, Pesticide Free Cannabis Plant
Overseeing the entire cultivation process, Autumn Brands’ Quality Control and Facilities Manager Justin Lough ensures a consistent, exceptional toke customers trust
LOS ANGELES, California – (March 26th, 2020): From clone to jar, 50% woman-owned Autumn Brands meticulously controls every part of the cannabis cultivation process, ensuring a consistently high quality, pesticide-free product from start to finish. Backed by decades of hard-won sustainable farming expertise, Autumn Brands stands out as a sixth-generation, family-run operation with a health-centered, holistic focus and refreshingly artisanal approach. Now, Quality Control and Facilities Manager Justin Lough offers an inside look at the lifecycle of an Autumn Brands cannabis plant.
“Customers know they can trust Autumn Brands to provide consistent, powerfully potent cannabis strains,” explains Lough. “We take immense pride in the quality of our product, paying close attention to every detail of our clean grow process.” That process starts with a cutting from a mother plant which, after cloning, enters a vegetative phase. Then, each plant is moved from the nursery to the greenhouse for flowering. Once fully flowered, they are hand-harvested and hang-dried for up to 12 days. This part is essential to remove excess moisture and activate the plant’s terpenes and THC content.
After drying, the Autumn Brands team begins the bucking and trimming process, removing flowers from their stems by hand with extreme care. Next, plants enter the two-week curing phase, in which they are kept at a low temperature and medium humidity level to help preserve their unique potency and ensure a smooth, flavorful toke. Then, they are placed in eco-friendly glass jars and transported by Autumn Brands’ distribution partner, Yerba Buena Logistics, for lab testing to verify THC and CBD levels, along with other beneficial cannabinoids. Finally, after passing the rigorous testing process, plants are ready to be delivered to dispensaries and enjoyed by consumers.
Every aspect of the Autumn Brands cultivation process requires strategic, hands-on precision and an uncompromising commitment to quality. Discover their top-notch collection of sustainably sourced, farm-to-consumer flower, pre-rolls, and pre-filled cartridges at select California dispensaries and online at www.AutumnBrands.com. Follow on Instagram @AutumnBrands for the latest product releases and updates.
About Autumn Brands:
Autumn Brands is a licensed California cannabis cultivator dedicated to the synergy of health and wellness. The Autumn Brands’ family farm started in Holland more than a century ago, and today, sixth-generation farmers apply the same expertise garnered in growing the world’s finest tulips to producing pure and potent strains of cannabis in sunny, coastal Santa Barbara County. Autumn Brands is proud to be 50 percent woman-owned, free of pesticides and other harmful chemicals. For more information, visit www.autumnbrands.com or email leighanne@anderson-pr.com.
QUARANTINE AND CHILL NEW CBD-INFUSED BODY OIL AND PAIN PATCH HELP YOU STAY CALM + WELL
Canna Bath Co. announces new additions to its line of handmade, all-natural CBD-infused products that address stress, promote relaxation, and invest in TLC during these tough times — perfect for taking care of yourself at home!
OAKLAND, CALIFORNIA – (MARCH 26, 2020) Focused on helping customers feel well, take better care of themselves, and find new ways to cope with stressful times, Canna Bath Co. announces the release of new self-care and pain relief products, the CBD Infused Topical Patch and CBD Body Oil. The new patch and body oil join a full line of CBD-infused bath bomb, bath salts, and body lotions already available from Canna Bath Co.
With so many of us staying at home and using social media right now to connect with friends and family, Canna Bath Co. is playing along, offering great contests and giveaways to its Instagram audience every week.
“I know the feeling of isolation can be quite overwhelming,” says founder and CEO Jessica Bernardo. “When you couple stress with anxiety, the combination can really be impactful. I hate to think of anyone suffering alone. All of my products help to address stress, promote relaxation, and encourage you to invest in TLC — which it is so needed right now!”
The newest addition to the Canna Bath Co. family, the Topical Patch ($39.95) provides slow-release CBD applications for up to eight hours. Sold in packs of three, each patch contains 40mg of hemp-based CBD. These patches are an excellent alternative to pills, powders, tinctures, and other palliatives due to their ease of use, long shelf life, time-release delivery, and convenience. External pain patches also go directly to work, avoiding both the digestive tract and the liver, so that the body can heal with less effort.
“I've never actually recommended a single marijuana product. But as a savvy patient who doctors himself as much as possible, I'm confident recommending Canna Bath's pain patches. . . . The bottom line is: don't tolerate pain unless you're a masochist and want it. ‘No pain, no gain’ is bull.”
—Jonah Raskin, “Drain the Pain,” North Bay Bohemian, March 18, 2020
Canna Bath Co.’s all natural CBD coconut body oil ($49.95) offers a lightweight non-greasy formula that can be used as an all over head-to-toe moisturizer and massage oil that’s ideal for broad coverage. As good for your nails as it is for your skin as it is for your hair, this CBD-infused body oil supports a sense of health and well-being so important right now.
Trained as a massage therapist, founder Jessica Bernardo, 34, has always had an interest in health and natural remedies. Making her own CBD-infused bath products with natural holistic ingredients that offer pain relief and produce glowing skin was a logical step.
Handmade with essential oils and therapeutic-grade CBD that has been third-party lab tested for quality and potency, Canna Bath Co. products are available at cannabathco.com, uncommongoods.com, and at select stores across the U.S.
Follow Canna Bath Co. on Instagram for a chance to be the first to learn of contests and giveaways as our community strives to come together, separately. https://www.instagram.com/cannabathco/
West Texas A&M Develops Antiviral Protection for Doors
Copper-based foil adhesive will be tested for effectiveness against COVID-19
CANYON, Texas — Biological warfare technology born at West Texas A&M University to protect soldiers from anthrax has been readapted and deployed across campus to protect door handles from viruses and bacteria.
Doors across West Texas A&M University soon will receive Copper Clean stickers over handles and push plates. The stickers — basically a highly engineered copper-alloy foil with an adhesive backing — are the newest product developed by Engineering Dean Emily Hunt and a group of ambitious graduate engineering students working to commercialize patents they have obtained for West Texas A&M University and The Texas A&M University System.
Along with standard infection control practices, these stickers will help alleviate the microbial burden on these high-touch surfaces across campus.
“The stickers are made with a copper-alloy that has been proven to kill 99.9 of harmful pathogens, like MSRA, Staph. auerus and E. coli within two hours,” Hunt said. Soon, they will be tested against other pathogens, including COVID-19.
“Sometimes a complex problem requires a common sense solution,” said John Sharp, chancellor of the Texas A&M System. “Dr. Hunt and her team deserve a lot of credit for doing their part to address the biggest problem facing the world today.”
Copper is one of the oldest known antimicrobials. Applying it to high-touch surfaces was a challenge Hunt and her materials science engineering students first took on in 2016.
“We recognized way back then that there are many surfaces in the world that our hands share with others,” Hunt said. “These areas, which we call ‘high-touch,’ are very susceptible to picking up, harboring and transferring microorganisms among people.”
Hunt, a Canyon native, began her research into antimicrobial materials in 2009 when she was awarded a grant from the U.S. Department of Defense and the National Science Foundation to pursue her ideas to protect soldiers and civilians from biological weapons of mass destruction.
The Department of Defense adopted Hunt’s ideas for use in military gas masks. Then she and her team worked to convert the military technology into commercial and consumer applications.
They formed Buffalo Technology Group, a Texas limited partnership whose stakeholders include West Texas A&M University, The Texas A&M University System and Frontier Capital Group, a private equity firm. Buffalo Technology Group has successfully patented and sold several products already, including MIC-Guard, a ceramic-metallic powder used in various coatings, linings and molded products in several industrial applications to inhibit iron-eating microorganisms and biofouling.
Copper Clean stickers are made at an EPA-approved, American manufacturer, Hunt said. The first batch arrive just this week. West Texas A&M University will be the first customer, but Hunt said Buffalo Technology Group is already talking to school districts across the state who are interested.
“At a time when the whole world is more cognizant than they have ever been about the prevalence and danger of harmful microorganisms, my hope for these patches is that they are implemented in areas were large quantities of healthy, sick and immunocompromised individuals share high-touch surfaces,” Hunt said.
The stickers are for sale for $24.50 at https://coppercleanus.com/. Proceeds from their sales will go back into funding more research on campus.
About The Texas A&M University System
The Texas A&M University System is one of the largest systems of higher education in the nation with a budget of $6.3 billion. The System is a statewide network of 11 universities; a comprehensive health science center; eight state agencies, including the Texas Division of Emergency Management; and the RELLIS Campus. The Texas A&M System educates more than 151,000 students and makes more than 22 million additional educational contacts through service and outreach programs each year. System-wide, research and development expenditures exceeded $1 billion in FY 2019 and helped drive the state’s economy.
OMA Welcomes the Government's $3.3B Investment to Support Ontario's Health Care System and Fight COVID-19
TORONTO, March 25, 2020 /CNW/ - The Ontario Medical Association (OMA) welcomes the substantive investment of $3.3 billion in new health care funding, including $2.1 billion to help physicians and other frontline health-care workers combat COVID-19. The OMA believes these initiatives will make a significant positive impact on our ability to respond to this unprecedented event.
"Ontario's 31,500 doctors are working tirelessly in difficult and often dangerous circumstances to provide the best possible care for their patients," said OMA President Dr. Sohail Gandhi. "In addition to the specific measures announced today, we are particularly heartened to see the establishment of a $1 billion COVID-19 contingency fund and $75 million for personal protective equipment and other critical medical supplies. The OMA has been advocating strongly to ensure our doctors and all front-line workers have what they need to safely care for patients."
"In the meantime, every one of us can help stem the spread of COVID-19," said Dr. Gandhi. "Stay home unless you have to go out. If you have to go out, keep a distance of at least two metres, or six feet, between you and other people. Please wash your hands thoroughly and often to prevent transferring the virus. And remember to stay in close contact with your friends and family. Physical distancing does not mean emotional distancing. We need each other's support now more than ever."
About the OMA The Ontario Medical Association represents Ontario's 43,000 plus physicians, medical students and retired physicians, advocating for and supporting doctors while strengthening the leadership role of doctors in caring for patients. Our vision is to be the trusted voice in transforming Ontario's health-care system.
SOURCE Ontario Medical Association
Corona Crow: The virus is a racist
MARCH 25, 2020
Greg Palast
You hear from every pol and pundit: The coronavirus does not distinguish between Black and White, rich and poor, Republican or Democrat.
That’s just bullshit.
This virus is one highly partisan little bug.
And a racist. Call it “Corona Crow.”
The virus attacks “the vulnerable.” And in our society, “vulnerable” does not refer to billionaire reality show hosts. Check out this Center for Disease Control chart based on studies using the Public Health Disparities Geocoding Project. Influenza hospitalization rates for impoverished African-Americans are three times the rate compared to non-poor whites.
Above: Age-adjusted incidence of influenza-related hospitalizations per 100,000 person-years by racial/ethnic group and census tract poverty level. FluSurv-NET, 14 states, 2010–2012
And the bug really, really likes Donald Trump. We have no choice: We’re all going to have to vote by mail if this malaise continues unabated. Or die.
But going postal will all but guarantee Trump’s re-election.
Providen Response to the Covid-19 Crisis
- Providen is prepared to help pharmacies, healthcare facilities, and communities that require support through the Covid-19 Pandemic -
WINNIPEG, March 25, 2020 /CNW/ - Pharmacists will play a critical role during the Covid-19 Outbreak in Canada. If we can look to Italy, Spain and other pandemic hot spots, pharmacies have been placed in challenging circumstances. They have been tasked with providing essential services to their patient networks. As the most accessible healthcare provider working on the front lines, pharmacy staff are challenged with extra workload to provide advice, dispense prescription, and non-prescription medications and to help close gaps in a strained healthcare environment. As Italy has also shown, pharmacies are also not only having to deal with increased workload and patient demand but also staff shortages, pharmacy closures and deaths as it relates to Covid-19 exposure. They have also moved as many as possible of their patients to a home delivery model to reduce staff exposure and provide products to infected or infirm patients.
Providen Pharmacy Logistics is a closed-door high-volume central fill pharmacy that provides packaging and distribution of prescription and non-prescription products to community pharmacies and correctional/healthcare facilities. Our industrial facilities can package compliance packaging, vial filling, unit of use and through our partner pharmacy, custom compounding all pursuant to a prescription. We can facilitate the fulfillment of large volumes of medications either sent in bulk, back to pharmacies ready for delivery or sent directly as individual orders to patients' homes. We are able to provide solutions to help patient contact pharmacies with workload and help to mitigate or deal with pharmacy closures.
Pharmacies in Canada will be challenged with many obstacles as it relates to their patients and communities. As part of a comprehensive pandemic plan Providen is notifying stakeholders that we are available to help in any way possible.
If you have any questions or would like to work directly with Providen to help with a solution please reach out to us as soon as possible as there are some time restrictions and work needed to get accounts set up.
About Providen Pharmacy Logistics Providen Pharmacy Logistics is a western Canadian pharmacy organization providing technology and central fill solutions to retail pharmacy and institutional healthcare facilities in Alberta, Saskatchewan and Manitoba. With the head office located in Winnipeg Manitoba, and a second facility in Calgary, Alberta, Providen has been providing back end logistic solutions since 2011.
SOURCE Providen Pharmacy Logistics
TRAIN IT RIGHT NEWSLETTER
Sign Up and get a free 7 day Train it Right HIIT Program!
